Invention Grant
- Patent Title: Combined CD6 and imipenem therapy for treatment of infectious diseases and related inflammatory processes
-
Application No.: US16462099Application Date: 2017-11-17
-
Publication No.: US11324804B2Publication Date: 2022-05-10
- Inventor: Francisco Lozano Soto , Mario Martinez Florensa
- Applicant: Sepsia Therapeutics, S.L.
- Applicant Address: ES Barcelona
- Assignee: Sepsia Therapeutics, S.L.
- Current Assignee: Sepsia Therapeutics, S.L.
- Current Assignee Address: ES Barcelona
- Agency: Seed Intellectual Property Law Group LLP
- Priority: EP16382540 20161118
- International Application: PCT/EP2017/079654 WO 20171117
- International Announcement: WO2018/091679 WO 20180524
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61P31/00 ; A61K31/198 ; A61K31/407
Abstract:
The present invention relates to the field of medicine and provides compositions and kits-of-parts comprising a CD6 product and Imipenem, in particular for their use in a therapeutic and/or preventive method of treatment, in a mammal including a human, of an infectious disease, or of an inflammatory condition related to an infectious disease, or of an inflammatory disease related to the presence of a product derived from an infectious agent.
Public/Granted literature
Information query
IPC分类:
